What's Happening?
A recent study conducted by the Brown University School of Public Health has shed light on federal enforcement actions against Medicare Advantage (MA) plans. The research, published in JAMA Internal Medicine, analyzed enforcement actions by the Centers
for Medicare & Medicaid Services (CMS) from 2010 to 2023. The study found that enrollment in MA plans has increased significantly, now covering over half of Medicare beneficiaries and receiving more than $494 billion in annual federal payments. The study examined 1,173 unique MA contracts and identified 844 enforcement actions, including civil money penalties, suspension of enrollment, and contract termination. The majority of these actions were monetary penalties, accounting for 87.3% of the total. The study highlighted that enforcement actions varied widely across the years, with financial penalties peaking at $6.50 per enrollee in 2019. The research concluded that the current design of oversight and enforcement actions may be insufficient to ensure compliance with federal standards.
Why It's Important?
The findings of this study are significant as they highlight the variability and potential inadequacy of current enforcement actions against Medicare Advantage plans. With MA plans covering a substantial portion of Medicare beneficiaries, robust oversight is crucial to protect patients and ensure that plans adhere to federal standards. The study raises concerns about the effectiveness of current enforcement measures, which may not be stringent enough to deter non-compliance. This has implications for policymakers and regulators who are responsible for safeguarding the integrity of the Medicare program. The study also points to disparities in enforcement actions, with contracts that received penalties often having lower star ratings and enrolling a lower share of White beneficiaries. This underscores the need for a more equitable and effective enforcement framework.
What's Next?
The study suggests that further evaluation of the design of oversight and enforcement actions is necessary to determine the appropriate level of enforcement needed to protect patients and ensure compliance with federal standards. Policymakers and regulators may need to consider revising the current enforcement framework to enhance its effectiveness. This could involve increasing the magnitude of penalties or implementing additional measures to ensure that Medicare Advantage plans meet the required standards. The findings may prompt discussions among stakeholders, including healthcare providers, insurers, and patient advocacy groups, about the best approaches to improve oversight and accountability in the Medicare Advantage program.
